Jeffery S Thompson insider trades: Anika Therapeutics (ANIK) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jeffery reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 11, 2022 | ANIK | ↑ Buy | 2,000 | $24.66 | $49K | Direct | Mar 15, 2022 (4d) |
| Aug 8, 2019 | ANIK | ↓ Sell | 4,843 | $56.66 | $274K | Direct | Aug 12, 2019 (4d) |
| May 22, 2017 | ANIK | ↓ Sell | 10,725 | $47.39 | $508K | Direct | May 23, 2017 (1d) |
| Jan 27, 2014 | ANIK | ↓ Sell | 10,346 | $45.82 | $474K | Direct | May 5, 2014 (98d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ANIK insiders
Open-market trades in the last 12 months
About Jeffery S Thompson's insider trades
Jeffery S Thompson is a director at Anika Therapeutics (ANIK). Since Jan 27, 2014, Jeffery has reported 1 open-market purchase worth $49K and 3 sales worth $1.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (16 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANIK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.